More News

20 Feb 2020 Caribou Biosciences and ProMab Biotechnologies Announce Sale and Assignment Agreement for Humanized scFv Targeting BCMA
20 Feb 2020 Five Prime Therapeutics Licenses Antibodies to Seattle Genetics for Use in Novel Antibody Drug Conjugate (ADC) Programs
19 Feb 2020 Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics
12 Feb 2020 OSE Immunotherapeutics Announces Artificial Intelligence Antibody Drug Development Collaboration with MAbSilico
10 Feb 2020 Blue Water Vaccines Licenses Patent Rights for Streptococcus Pneumoniae Vaccine Development from St. Jude Children's Research Hospital
06 Feb 2020 Atreca Announces Strategic Research Collaboration with Merck to Identify Novel Antibody Targets in Oncology
05 Feb 2020 Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development of Next-Generation Food Allergy Treatments
04 Feb 2020 SIRION Biotech Licenses Adenovirus Technology to Danish Startup, InProTher for its Novel Immunotherapy Design Targeting Endogenous Retrovirus (ERV)
04 Feb 2020 EyePoint Pharmaceuticals Signs Exclusive License Agreement with Equinox Science to Develop Tyrosine Kinase Inhibitor Vorolanib for the Treatment of Wet AMD, Diabetic Retinopathy and Retinal Vein Occlusion
03 Feb 2020 AgeX Therapeutics to Collaborate with University of California, Irvine on Neural Stem Cell Research Program for Huntington’s Disease and Other Neurological Disorders
03 Feb 2020 IMIDomics and Gossamer Bio Enter into a Strategic Collaboration to Advance the Development of Novel Treatments for Patients with Immune-Mediated Inflammatory Diseases
29 Jan 2020 Conatus Pharmaceuticals and Histogen Enter into Definitive Merger Agreement
28 Jan 2020 Syndivia In-Licenses DARx Technology for 1-to-1 Linkage of Antibodies and Payloads for Preparation of New Classes of Biologics
22 Jan 2020 Ocuphire Pharma Announces In-License of Phase 2 Oral Small Molecule Drug Candidate for Diabetic Retinopathy and Diabetic Macular Edema from Apexian Pharmaceuticals
21 Jan 2020 Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes
21 Jan 2020 PhoreMost enters multi-project drug discovery collaboration with Otsuka Pharmaceutical
17 Jan 2020 Syndivia In-Licenses Novel Antibody Against Tumor-Specific Form of CD146 From SATT Sud-Est
17 Jan 2020 BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
16 Jan 2020 Fibrocor and Galapagos sign expanded collaboration in fibrosis
15 Jan 2020 Artisan Bio Announces Global Research and Discovery Collaboration Agreement with Takeda to Develop Next-Generation Cell Therapy Products
15 Jan 2020 Dermavant Enters into Exclusive License Agreement with JT for Development and Commercialization of Tapinarof in Japan
14 Jan 2020 Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies
14 Jan 2020 Allele and Astellas Enter into an Expanded License for the Development of iPSC Lines
13 Jan 2020 Editas Medicine and Sandhill Therapeutics, Inc. Announce Collaboration to Develop Engineered Cell Medicines to Treat Cancer
13 Jan 2020 Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular degeneration (AMD) and Diabetic Macular Oedema (DMO)

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top